Phase Ia/1b Multiple Ascending Dose Study to Assess the safety, Pharmacokinetics and Pharmacodynamics of SB 9200 in Treatment Na�ve HCV Infected Adults

Grant number: 2I981 | Funding period: 2013 - 2018

Completed

University of Melbourne Researchers